vers la météo de la validation par utilisateur

Ingenuity377

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 32 - PMID ?

__NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hyperlipidemia .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
     +------------------------SUBJ:V_PASS-N------------------------+                                                                        
     |             +--------COMP:N-N(of)-------+                   |                                                                        
     |             |           +-MOD_ATT:N-ADJ-+                   |           +------COMP:N-N(of)-----+      +---COMP:ADJ-N(to)---+        
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              +MOD_ATT:+MOD_PO+         +MOD_ATT:N-+        
     |             |           |       |       |                   |           |              |        |      |         |          |        
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hyperlipidemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,drug)
MOD_ATT:N-N (drug,combination)
MOD_POST:N-ADJ (drug,__NODE__)
COMP:ADJ-N(to) (__NODE__,hyperlipidemia)
MOD_ATT:N-N (hyperlipidemia,treat)
Analyse 1 
     +------------------------SUBJ:V_PASS-N------------------------+                                                                        
     |             +--------COMP:N-N(of)-------+                   |           +--------MOD_POST:N-ADJ--------+                             
     |             |           +-MOD_ATT:N-ADJ-+                   |           +------COMP:N-N(of)-----+      +---COMP:ADJ-N(to)---+        
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              +MOD_ATT:+      |         +MOD_ATT:N-+        
     |             |           |       |       |                   |           |              |        |      |         |          |        
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hyperlipidemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,drug)
MOD_POST:N-ADJ (part,__NODE__)
MOD_ATT:N-N (drug,combination)
COMP:ADJ-N(to) (__NODE__,hyperlipidemia)
MOD_ATT:N-N (hyperlipidemia,treat)
Analyse 2 
     +------------------------SUBJ:V_PASS-N------------------------+-----------------------COMP:V_PASS-N(to)-----------------------+        
     |             +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+                    |        
     |             |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+                    |        
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +MOD_ATT:N-+        
     |             |           |       |       |                   |           |              |        |      |         |          |        
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hyperlipidemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:V_PASS-N(to) (approve,hyperlipidemia)
COMP:N-N(of) (part,__NODE__)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
MOD_ATT:N-N (hyperlipidemia,treat)
Analyse 3 
     +------------------------SUBJ:V_PASS-N------------------------+                                                                        
     |             +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+                             
     |             |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+----COMP:N-N(to)----+        
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +MOD_ATT:N-+        
     |             |           |       |       |                   |           |              |        |      |         |          |        
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hyperlipidemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,__NODE__)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
COMP:N-N(to) (__NODE__,hyperlipidemia)
MOD_ATT:N-N (hyperlipidemia,treat)
Analyse 4 
     +------------------------SUBJ:V_PASS-N------------------------+           +--------------------COMP:N-N(to)-------------------+        
     |             +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+                    |        
     |             |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+                    |        
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +MOD_ATT:N-+        
     |             |           |       |       |                   |           |              |        |      |         |          |        
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hyperlipidemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,__NODE__)
COMP:N-N(to) (part,hyperlipidemia)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
MOD_ATT:N-N (hyperlipidemia,treat)
Analyse 5 
                                                                   +------------------COMP:V_PASS-V(to)-----------------+                   
                   +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+         |                   
                   |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+         |                   
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +--OBJ:V-N-+        
     |             |           |       |       |                   |           |              |        |      |         |          |        
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hyperlipidemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:V_PASS-V(to) (approve,treat)
COMP:N-N(of) (part,__NODE__)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
OBJ:V-N (treat,hyperlipidemia)